Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Third Interim Dividend

24 Jun 2021 13:34

RNS Number : 0401D
Aberdeen Latin American Inc Fd Ltd
24 June 2021
 

Aberdeen Latin American Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

24 June 2021

 

Third Interim Dividend

The Board is pleased to declare a third interim dividend of 0.875 pence per Ordinary share (2020: 0.875p) in respect of the year ending 31 August 2021 payable on 30 July 2021 to Ordinary shareholders on the register at close of business on 9 July 2021 (ex-dividend date 8 July 2021).

The current level of dividend continues to be maintained, supplemented by revenue reserves, despite the weakening of Latin American currencies against sterling predominantly due to the impact of the Covid-19 pandemic and the continuing economic effects on the Company's equity investments, many of which have scaled back their distributions to conserve cash where possible through lockdowns. This has meant that the sterling income receipts of the Company have been reduced.

It is the Directors' current intention to utilise revenue reserves to maintain the payments at the same level for the year ending 31 August 2021.

If the volatility experienced in the region continues and currencies remain weak, the Directors believe that it is likely that the payment of a sustainable and covered dividend may necessitate a lower dividend payment in future years. The Directors continue to review closely the robustness of the Company's investments and its balance sheet and to monitor closely the impact of Covid-19 and associated vaccine rollouts, together with the ramifications for the region, valuations and recurring earnings, while balancing the income requirements of its shareholders, and will continue to keep its distribution policy under close review.

Aberdeen Standard Capital International Limited

Manager and Company Secretary

 

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBDGDLXXDDGBS
Date   Source Headline
27th Feb 202312:36 pmRNSNet Asset Value(s)
24th Feb 20231:33 pmRNSNet Asset Value(s)
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:59 amRNSNet Asset Value(s)
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20234:07 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:30 pmRNSNet Asset Value(s)
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20231:29 pmRNSNet Asset Value(s)
6th Feb 20234:04 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:43 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20231:01 pmRNSNet Asset Value(s)
31st Jan 202312:34 pmRNSNet Asset Value(s)
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 20234:14 pmRNSHolding(s) in Company
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 202312:32 pmRNSNet Asset Value(s)
24th Jan 202312:59 pmRNSNet Asset Value(s)
23rd Jan 20234:23 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 202312:43 pmRNSNet Asset Value(s)
18th Jan 20235:10 pmRNSNet Asset Value(s)
18th Jan 202310:53 amRNSPortfolio disclosure
17th Jan 202312:19 pmRNSNet Asset Value(s)
16th Jan 20232:12 pmRNSGearing disclosure
16th Jan 20231:05 pmRNSNet Asset Value(s)
13th Jan 20231:08 pmRNSNet Asset Value(s)
12th Jan 202312:05 pmRNSNet Asset Value(s)
11th Jan 202311:10 amRNSNet Asset Value(s)
10th Jan 202312:02 pmRNSNet Asset Value(s)
9th Jan 20235:18 pmRNSGearing disclosure
9th Jan 202312:13 pmRNSNet Asset Value(s)
6th Jan 20233:03 pmRNSMonth End Net Asset Value(s)
6th Jan 202312:52 pmRNSNet Asset Value(s)
5th Jan 202312:11 pmRNSNet Asset Value(s)
4th Jan 202312:22 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.